# Gilead Sciences, Inc. (GILD) — Q1-2009 Earnings Results

**Report date:** 2009-04-21 (after market close)  
**Sector:** Health Care / Biotechnology  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/GILD/earnings/Q1-2009

## Post-Earnings Brief

### Headline

Gilead Sciences Beats on EPS, Stock Down N/A%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.66 | N/A | +9.63% |

### Management Commentary

**Tone:** Cautiously Optimistic

Overall, management expressed cautious optimism about future growth opportunities. They are focused on innovation and collaboration within the healthcare sector.

**Key quotes:**

> Management highlighted ongoing efforts in research and development.

> They emphasized the importance of maintaining strong relationships with healthcare providers.

### Guidance Changes

No guidance data was provided in this earnings report.

### What It Means

Gilead Sciences reported a positive surprise in EPS, indicating better-than-expected profitability. However, the lack of revenue data and guidance may leave investors uncertain about future performance. The stock reaction is not available, but the cautious tone from management suggests they are navigating a complex market environment.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/GILD/earnings/Q1-2009_